Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 15018-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#15018-1-AP, RRID:AB_2120506
- Product name
- HNRNPR antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated HNRNPR antibody (Cat. #15018-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The hnRNPK/A1/R/U Complex Regulates Gene Transcription and Translation and is a Favorable Prognostic Biomarker for Human Colorectal Adenocarcinoma.
High expression of HNRNPR in ESCA combined with (18)F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA.
Increased LDL receptor by SREBP2 or SREBP2-induced lncRNA LDLR-AS promotes triglyceride accumulation in fish.
hnRNPM deficiency leads to cognitive deficits via disrupting synaptic plasticity.
Novel facile thermosensitive hydrogel as sustained and controllable gene release vehicle for breast cancer treatment.
HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins.
Li Y, Wang H, Wan J, Ma Q, Qi Y, Gu Z
Frontiers in oncology 2022;12:845931
Frontiers in oncology 2022;12:845931
High expression of HNRNPR in ESCA combined with (18)F-FDG PET/CT metabolic parameters are novel biomarkers for preoperative diagnosis of ESCA.
Liu XY, Gao Y, Kui XY, Liu XS, Zhang YH, Zhang Y, Ke CB, Pei ZJ
Journal of translational medicine 2022 Oct 4;20(1):450
Journal of translational medicine 2022 Oct 4;20(1):450
Increased LDL receptor by SREBP2 or SREBP2-induced lncRNA LDLR-AS promotes triglyceride accumulation in fish.
Cao X, Fang W, Li X, Wang X, Mai K, Ai Q
iScience 2022 Jul 15;25(7):104670
iScience 2022 Jul 15;25(7):104670
hnRNPM deficiency leads to cognitive deficits via disrupting synaptic plasticity.
Akinyemi AR, Li D, Zhang J, Liu Q
Neuroscience letters 2021 Apr 23;751:135824
Neuroscience letters 2021 Apr 23;751:135824
Novel facile thermosensitive hydrogel as sustained and controllable gene release vehicle for breast cancer treatment.
Zhao D, Song H, Zhou X, Chen Y, Liu Q, Gao X, Zhu X, Chen D
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 Jun 15;134:145-152
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 Jun 15;134:145-152
HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins.
Reches A, Nachmani D, Berhani O, Duev-Cohen A, Shreibman D, Ophir Y, Seliger B, Mandelboim O
Journal of immunology (Baltimore, Md. : 1950) 2016 Jun 15;196(12):4967-76
Journal of immunology (Baltimore, Md. : 1950) 2016 Jun 15;196(12):4967-76
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HepG2 cells were subjected to SDS PAGE followed by western blot with 15018-1-AP(HNRNPR antibody) at dilution of 1:300
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human brain using 15018-1-AP(HNRNPR antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The HNRNPR antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human HNRNPR. This antibody recognizes human, mouse, rat antigen. The HNRNPR antibody has been validated for the following applications: ELISA, WB, IHC analysis.